Author:
Giubilei F.,Sarrantonio A.,Tisei P.,Gasperini C.,Salvetti M.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Neuroscience,Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Reference11 articles.
1. Allen IV.Demyelinating diseases. In: Adams LH, Corsellis JAN, Duchen LW, eds. Greenfield's neuropathology. 4th ed. New York: Wiley Medical, 1985: 338–384.
2. Barkhof F, Tas MW, Frequin STFM, et al.Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis. Neuroradiology, 1994; 36: 382–387.
3. De Angelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G.Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology, 1990; 40: 80–86.
4. Frequin STFM, Barkhof F, Lamers KJB, Hommes OR, Borm GF.CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone. Acta Neurol Scand, 1992; 86: 291–297.
5. Johnson MD, Lavin P, Whetsell WO Jr. Fulminant monophasic multiple sclerosis, Marburg's type. J Neurol Neurosurg Psychiatry, 1990; 53: 918–921.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献